ChatGPT Outperformed Trainee Doctors in Assessing Complex Respiratory Illness in Children

The chatbot ChatGPT performed better than trainee doctors in assessing complex cases of respiratory disease in areas such as cystic fibrosis, asthma and chest infections in a study presented at the European Respiratory Society (ERS) Congress in Vienna, Austria.

The study also showed that Google’s chatbot Bard performed better than trainees in some aspects and Microsoft’s Bing chatbot performed as well as trainees.

The research suggests that these large language models (LLMs) could be used to support trainee doctors, nurses and general practitioners to triage patients more quickly and ease pressure on health services.

The study was presented by Dr Manjith Narayanan, a consultant in paediatric pulmonology at the Royal Hospital for Children and Young People, Edinburgh and honorary senior clinical lecturer at the University of Edinburgh, UK. He said: “Large language models, like ChatGPT, have come into prominence in the last year and a half with their ability to seemingly understand natural language and provide responses that can adequately simulate a human-like conversation. These tools have several potential applications in medicine. My motivation to carry out this research was to assess how well LLMs are able to assist clinicians in real life.”

To investigate this, Dr Narayanan used clinical scenarios that occur frequently in paediatric respiratory medicine. The scenarios were provided by six other experts in paediatric respiratory medicine and covered topics like cystic fibrosis, asthma, sleep disordered breathing, breathlessness and chest infections. They were all scenarios where there is no obvious diagnosis, and where there is no published evidence, guidelines or expert consensus that point to a specific diagnosis or plan.

Ten trainee doctors who had less than four months of clinical experience in paediatrics were given an hour where they could use the internet, but not any chatbots, to solve each scenario with a descriptive answer of 200 to 400 words. Each scenario was also presented to the three chatbots.

All the responses were scored by six paediatric respiratory experts for correctness, comprehensiveness, usefulness, plausibility, and coherence. They were also asked to say whether they thought each response was human- or chatbot-generated and to give each response an overall score out of nine.

Solutions provided by ChatGPT version 3.5 scored an average of seven out of nine overall and were believed to be more human-like than responses from the other chatbots. Bard scored an average of six out of nine and was scored as more ‘coherent’ than trainee doctors, but in other respects was no better or worse than trainee doctors. Bing scored an average of four out of nine - the same as trainee doctors overall. Experts reliably identified Bing and Bard responses as non-human.

Dr Narayanan said: “Our study is the first, to our knowledge, to test LLMs against trainee doctors in situations that reflect real-life clinical practice. We did this by allowing the trainee doctors to have full access to resources available on the internet, as they would in real life. This moves the focus away from testing memory, where there is a clear advantage for LLMs. Therefore, this study shows us another way we could be using LLMs and how close we are to regular day-to-day clinical application.

"We have not directly tested how LLMs would work in patient facing roles. However, it could be used by triage nurses, trainee doctors and primary care physicians, who are often the first to review a patient."

The researchers did not find any obvious instances of ‘hallucinations’ (seemingly made-up information) with any of the three LLMs. "Even though, in our study, we did not see any instance of hallucination by LLMs, we need to be aware of this possibility and build mitigations against this," Dr Narayanan added. Answers that were judged to be irrelevant to the context were occasionally given by Bing, Bard and the trainee doctors.

Dr Narayanan and his colleagues are now planning to test chatbots against more senior doctors and to look at newer and more advanced LLMs.

Hilary Pinnock is ERS Education Council Chair and Professor of Primary Care Respiratory Medicine at The University of Edinburgh, UK, and was not involved in the research. She says: "This is a fascinating study. It is encouraging, but maybe also a bit scary, to see how a widely available AI tool like ChatGPT can provide solutions to complex cases of respiratory illness in children. It certainly points the way to a brave new world of AI-supported care.

"However, as the researchers point out, before we start to use AI in routine clinical practice, we need to be confident that it will not create errors either through ‘hallucinating’ fake information or because it has been trained on data that does not equitably represent the population we serve. As the researchers have demonstrated, AI holds out the promise of a new way of working, but we need extensive testing of clinical accuracy and safety, pragmatic assessment of organisational efficiency, and exploration of the societal implications before we embed this technology in routine care."

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...